Management of Rheumatic Heart Diseases in Burundi
- Authors: Ndirahisha E.1, Baransaka E.1, Nyandwi J.1, Bukuru H.1, Muserebanyi C.1, Nimburanira M.2, Nyandwi R.1
-
Affiliations:
- University of Burundi
- Military Hospital of Kamenge, Service of Cardiology
- Issue: Vol 23, No 3 (2019)
- Pages: 290-296
- Section: CARDIOLOGY
- URL: https://journals.rudn.ru/medicine/article/view/22517
- DOI: https://doi.org/10.22363/2313-0245-2019-23-3-290-296
Cite item
Full Text
Abstract
Background: The surgical management of rheumatic heart disease (RHD) in Burundi is almost impossible because of the absence of the technical plateau. Aim: To describe the therapeutic and evolutionary aspects of RHD in Burundi. Patients and methods: This is a retrospective and analytical study of patients' records in surgical indication and/or operated for RHD by facilitation of “Maison du Bon Samaritain du Burundi (MBSB)” from February 2015 to February 2017. Results: Among 89 patients consulting for RHD, 45 (50.56%) were operated. The average age of the patients was 25 years. Females predominated with 64.04% of cases. The age of most of patients was between 4 and 40 years with 74 cases (83.14%). All patients had been received at the heart failure stage including 83 (93.25%) at stage III or IV according to the New York Heart Association (NYHA) classification. The ejection fraction was ≤ 50% in 61 patients (68.53%). Pulmonary arterial hypertension was recorded in 79 patients (88.76%). On chest X-ray, cardiomegaly was found in 85 patients (95.50%). Electrical abnormalities were dominated by dilatation of the left atrium in 48 cases (53.93%). Isolated valvular lesions were the most numerous with 67 cases (75.28%). The operative management was mainly valvular replacement (93.47%) with an operative success of 100% six months after the intervention. Conclusion: The diagnosis of RHD was late. Young people were more vulnerable. The postoperative prognosis at six months was good.
Keywords
About the authors
E. Ndirahisha
University of Burundi
Author for correspondence.
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
E. Baransaka
University of Burundi
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
J. Nyandwi
University of Burundi
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
H. Bukuru
University of Burundi
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
C. Muserebanyi
University of Burundi
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
M. Nimburanira
Military Hospital of Kamenge, Service of Cardiology
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
R. Nyandwi
University of Burundi
Email: kabandeugene@yahoo.fr
Bujumbura, Burundi
References
- Kingué S., Ba S.A., Baldé D., Diarra M.A., Anzoua-Kacou J.B., Anisubia B. et al. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Arch. Cardiovasc. Dis. 2016; 109: 321-29.
- Essop M.R., Nkomo V.T. Rheumatic and no rheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005; 12: 3584-40.
- Kimbally-Kaky G., Gombet T., VoumboY., Ikama-Méo S., Elenga-Mbola B., Mbika-Cardorelle A. et al. Rheumatic heart disease in schoolchildren in Brazzaville. Med Trop. 2008; 68: 603-5.
- Guidelines on the management of valvular heart disease (version 2012). The joint task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic surgery (EACTS). European Heart Journal. 2012; 33: 2451-96.
- République du Burundi. Troisièmeenquête démographiqueet de santé 2016-2017. The DHS Program, ICF, Rockville, Mary Land, USA. 2017: 9-13.
- Zühlke L., Engel M.E., Kurthikeyan G., Rangarajan S, Cupido M.B.P., Mauff K. et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal. 2015; 36 (18): 1115-32.
- Somnoma J.B.T., Senkaye L.A.K., Yaméogo A.A., Yaméogo N.B. Les cardiopathies de l’enfant au CHU SouroSanou de Bobo-Dioulasso: aspects échographiques et thérapeutiques. Med d’Afr Noire. 2016; 9 (5/6): 1-4.
- Goeh A.E., Gbeasor F.D., Baragou S., Damorou F., Gbadoe A.D., Kessie K., AtakoumaDy, Soussou B.L. Les cardiopathiesrhumatismales au Centre Hospitalier Universitaire Tokoin de Lomé. Rev CAMES, Série A, Vol. 06, 2008:12-7.
- Manjunath C.N., Srinivas P., Ravindranath K.S., Dhanalakshmi C. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: A single center experience. Indian Heart J. 2014; 66(3): 320-6.
- Carapetis J.R. Rheumatic heart disease in developing countries. N Engl J Med. 2007; 357-441.
- Diao K., Kane A., Doumbia A., Leye M.M., Mbaye A., Kane A. et al. Cardiopathiesrhumatismalesévolutives à propos de 17 cascolligés au CHU de Dakar. Med trop. 2005 (65): 339.
- Slama R., Motté G., Leenhardt A., Sebag C. Aide-mémoire de rythmologie. 2ième Edition; Flammarion Médecine-Sciences; Paris. 2003: 112-30.
- Mucumbitsi J. Cardiac surgery for advanced rheumatic disease in Rwanda. Cardiovasc J Afr. 2016; 27(3): 184-7.
- Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J; 2012 (33), 2451-96.
- Barsoum P.M., Mirabel M., Iung X.J.B., Marijon E., Patricia R. Pronostic des interventions valvulairesparmi les populations autochtonesen Nouvelle Calédonie. Circulation. 2015; 13 (15): 1024 9.
- Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5(11):685 94.
- Vassileva C.M., Mishkel G., Neely C.M., Boley T., Markwell S., Scaife S. et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation. 2013; 127(18): 1870-6